DTZ Am Frankfurter Tor Diagnostisch Therapeutisches Zentrum

What DTZ Am Frankfurter Tor Diagnostisch Therapeutisches Zentrum does

DTZ Berlin is a certified outpatient medical care center (Medizinisches Versorgungszentrum, MVZ) operating two physical locations in Berlin — the primary site at Kadiner Straße 23 in Berlin-Friedrichshain and a second site at the OZB Onkozentrum Berlin in Berlin-Köpenick, the latter jointly operated with DRK Kliniken Berlin Köpenick since December 2020. Founded around 1995 and led by Prof. Dr. Wolfgang Mohnike (founder) and Priv.-Doz. Dr. Konrad Mohnike (Medical Director at Frankfurter Tor), the center integrates nuclear medicine, radiology, hybrid imaging, and radiotherapy under one roof. Its core technology stack includes PET/CT, PET/MR, SPECT/CT, 3T and 1.5T MRI, CT, digital mammography with tomosynthesis, ultrasound, scintigraphy, TomoTherapy (TomoHD), IMRT/VMAT, IGRT, stereotaxy, brachytherapy, and a GMP-compliant in-house radiochemistry facility (operational since 2009) that manufactures its own radiopharmaceuticals. DTZ was the first outpatient PET/CT provider in Germany (October 2003 BAR approval) and achieved EARL PET/CT accreditation in 2023.

The center serves patients with statutory health insurance (GKV) and private insurance across oncology, benign diseases, and palliative care, with specialty focus on prostate cancer (PSMA-PET/CT, Lutetium-PSMA theranostics), thyroid disease, cardiac imaging, and radiotherapy for benign inflammatory conditions. Patient acquisition is driven by physician referrals, hospital partnerships (Charité, HELIOS, Vivantes, Sana, Otto-von-Guericke-Universität Magdeburg), and contracted relationships with major German health insurers including Techniker Krankenkasse, DAK-Gesundheit, AOK Nordost, AOK Bayern, and BMW BKK. Operational marketing emphasizes physician education through the annual Berliner PET/CT Symposium (23rd edition scheduled June 2026) and CME-certified training events.

DTZ generates revenue through German GKV reimbursement (EBM catalog) and private insurance billing for diagnostic and therapeutic procedures across its multi-modality service portfolio. The OZB joint venture creates a unique intersectoral model combining outpatient and inpatient oncology care. The center does not disclose revenue figures, has no identified parent company, and operates as an independent physician-led organization.

Name

DTZ Am Frankfurter Tor Diagnostisch Therapeutisches Zentrum

Legal name

Diagnostisch Therapeutisches Zentrum Berlin (DTZ)

Website

https://berlin-dtz.de

Company type

Private

Founded year

1995

Operating status

Operating

Headcount range

11–50 employees

Short description

DTZ Berlin is a Berlin-based outpatient medical care center (MVZ) specializing in nuclear medicine, radiology, hybrid imaging (PET/CT, PET/MR), and radiotherapy, operating two locations including the OZB Onkozentrum Berlin joint venture with DRK Kliniken, serving statutory and private insured patients.

Ownership category

akta.pro rank

Product category

Outpatient Diagnostic Imaging and Radiotherapy Services

NAICS

Diagnostic Imaging Centers (621512)

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology) (HLAFAKAB)

akta.pro secondary industries

Radiation Oncology (HLAKAFAC), Therapeutic Radiopharmaceuticals (Radioligand/Targeted Radionuclide Therapy) (HLAIAGAB), Radiopharmacy Compounding & Dispensing (Hospital/Commercial) (HLAIAGAE)

Keywords

• Outpatient diagnostic imaging
• Radiotherapy services
• Nuclear medicine diagnostics
• Hybrid imaging PET/CT
• Oncology treatment services

Headquarters

HQ city

Berlin-Friedrichshain

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Ambulatory Medical Services (GKV and Private): DTZ operates as a certified outpatient medical care center (Medizinisches Versorgungszentrum, MVZ) billing patients and insurers for diagnostic and therapeutic services. Revenue is generated through reimbursement from statutory health insurance (Gesetzliche Krankenversicherung, GKV) and private health insurers. As a 'Bestellpraxis' (appointment-based practice), they schedule treatments in advance and charge for no-shows (60 EUR cancellation fee for appointments cancelled less than 24 hours in advance). The center provides a broad range of services across nuclear medicine, radiology, hybrid imaging, and radiotherapy, all billed through the German healthcare reimbursement system.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Core offering

DTZ Berlin operates as a certified outpatient medical care center (MVZ) delivering integrated diagnostic and therapeutic services spanning nuclear medicine, radiology, hybrid imaging, and radiotherapy. The center combines PET/CT, PET/MR, SPECT/CT, MRI, CT, mammography, ultrasound, and scintigraphy for diagnostics with TomoTherapy, IMRT/VMAT, IGRT, stereotactic radiotherapy, and brachytherapy for treatment. Since 2009 it has maintained an in-house GMP radiochemistry facility producing its own radiopharmaceuticals for diagnostic procedures.

Product overview

DTZ Berlin operates as a certified medical care center (MVZ) offering integrated diagnostic and therapeutic services in nuclear medicine, radiology, hybrid imaging, and radiotherapy. The center functions as a platform combining multiple specialized departments: Center for Nuclear Medicine (PET/CT, PET/MR, SPECT/CT, Szintigraphie), Center for Radiology (CT, MRT, Ultrasound, X-ray, Mammography), Center for Radiotherapy (TomoTherapy, IMRT/VMAT, IGRT, Stereotaxy), and DTZ Therapy GbR for radiotherapy treatments. Services include cancer diagnostics and treatment, benign disease radiotherapy, palliative medicine, PSMA-PET/CT, and theranostics. Two locations serve patients: DTZ Berlin at Frankfurter Tor (Friedrichshain) and DTZ at OZB Onkozentrum Berlin (Köpenick), in partnership with DRK Kliniken Berlin Köpenick.

Differentiator

Problem solved

Functional benefit

Brands

• OZB Onkozentrum Berlin: Joint oncology center with DRK Kliniken Berlin Köpenick offering comprehensive cancer care
• DTZ Privatklinik am OZB
• Prostata-Kompetenzzentrum im OZB

Products and services

• PET/CT Diagnostics Positron Emission Tomography combined with Computed Tomography for oncological and neurological diagnostics, including hybrid imaging capabilities. EARL-accredited since 2023.
• PET/MR Diagnostics Positron Emission Tomography combined with Magnetic Resonance imaging for advanced oncological diagnostics without ionizing radiation exposure, using a MAGNETOM 3T PET/MR system.
• SPECT/CT and SPECT/MR Hybrid Imaging Hybrid imaging combining Single Photon Emission Computed Tomography with CT or MR for nuclear medicine diagnostics.
• Scintigraphy (Szintigraphie) Function-based nuclear medicine imaging using radioactively labeled substances to visualize organ structures and function.
• CT (Computed Tomography)
• MRI (Magnetic Resonance Imaging)
• Ultrasound (Sonography)
• Conventional X-ray (Konventionelles Röntgen)
• Mammography with Tomosynthesis (Mammographie)
• Cardiac SPECT (Herz-SPECT) Cardiac SPECT imaging including amyloidosis detection capabilities, using the Discovery NM 530c system for myocardial imaging.
• Bone Densitometry (Knochendichtemessung)
• Radiotherapy (Strahlentherapie) External beam radiotherapy for cancer and benign conditions using Elekta Versa HD linear accelerator technology, including respiratory gating, radiosurgery, and VMAT.
• Tomotherapy (TomoTherapy)
• IMRT/VMAT
• IGRT (Image-Guided Radiotherapy)
• Stereotactic Radiotherapy (Stereotaxie)
• Interventional Oncology (Interventionelle Onkologie)
• Radiochemistry (Radiochemie) In-house radiopharmaceutical production facility established 2009 for manufacturing diagnostic tracers under GMP guidelines, ensuring supply chain control.
• Radionuclide Therapy (Radionuklidtherapie)
• PSMA-PET/CT Prostate Diagnostics
• DTZ Privatklinik am OZB Private clinic for radionuclide therapy and theranostics, part of the OZB Onkozentrum Berlin campus, with a radionuclide therapy station adjacent to DRK Kliniken's oncology ward.
• Palliative Medicine (Palliativmedizin)
• Brachytherapy (Brachytherapie) Internal radiation therapy using radioactive sources placed near or within tumors.
• Prostate Competence Center (Prostata-Kompetenzzentrum) Interdisciplinary center for prostate disease diagnosis and treatment at OZB Onkozentrum Berlin, offering PSMA-PET/CT and Lutetium-PSMA theranostics.

Quantifiable outcome

• First outpatient PET/CT facility in Germany, establishing over 20 years of specialized experience in hybrid imaging
• +1 more outcomes

Named customers6 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature12 records

Partnerships

13 partnerships are on record, tiered core and minor.

• DRK Kliniken Berlin KöpenickcoreStrategic or Co-development PartnerDRK Kliniken Berlin Köpenick is DTZ's most significant strategic partner. Together they founded the OZB Onkozentrum Berlin, a unique intersectoral oncology center combining outpatient and inpatient care under one roof. The partnership integrates DTZ's outpatient diagnostics and radiotherapy with DRK Kliniken's inpatient services (interdisciplinary oncology ward). The OZB opened in December 2020 and represents the first outpatient-inpatient oncology center in southeast Berlin. The partnership also includes the DTZ Privatklinik am OZB, which operates a radionuclide therapy station adjacent to DRK Kliniken's interdisciplinary oncology ward.
• Charité – Universitätsmedizin Berlin (Otto-Heubner-Centrum)minorStrategic or Co-development PartnerCooperation with Charité Campus Benjamin Franklin (Medical Clinic III – Haematology, Oncology, Transfusion Medicine) and Otto-Heubner-Centrum for Pediatric and Adolescent Medicine, Social Pediatric Center. Academic hospital partnerships for patient referrals and medical education.
• HELIOS Klinikum Emil von Behring (Lungenklinik Heckeshorn)minorStrategic or Co-development PartnerCooperation with the lung clinic (Lungenklinik Heckeshorn) at HELIOS Klinikum Emil von Behring for patient referrals in pulmonary oncology cases.
• Otto-von-Guericke-Universität Magdeburg (Klinik für Radiologie und Nuklearmedizin, Zentrum für Kinderheilkunde)minorStrategic or Co-development PartnerCooperation with the University of Magdeburg's Clinic for Radiology and Nuclear Medicine and Center for Pediatrics. Academic partnership for research collaboration and patient referrals.
• Sana Klinikum Lichtenberg (Frauenklinik und Brustzentrum)minorStrategic or Co-development PartnerPartnership with Sana Klinikum Lichtenberg's Women's Clinic and Breast Center for mammography referrals and breast cancer diagnosis/treatment coordination.
• Vivantes-Klinikum im FriedrichshainminorStrategic or Co-development PartnerCooperation with Vivantes Hospital in Friedrichshain for patient referrals and collaborative oncology care in the local Berlin area.
• Techniker Krankenkasse (TK)coreGTM or Marketing PartnerPartnership with Germany's largest statutory health insurer. DTZ published a specialized co-branded information brochure on high-tech PET/CT cancer diagnostics specifically for TK policyholders. TK patients have facilitated access to DTZ's diagnostic and therapeutic services.
• DAK-GesundheitminorGTM or Marketing PartnerPartnership with DAK-Gesundheit, one of Germany's large statutory health insurers, for reimbursement and patient access.
• AOK Nordost and AOK BayernminorGTM or Marketing PartnerPartnerships with AOK Nordost (operating in Berlin/Brandenburg) and AOK Bayern for statutory health insurance reimbursement of diagnostic and therapeutic services.
• BMW BKKminorGTM or Marketing PartnerPartnership with BMW BKK company health insurance fund for reimbursement and patient access at DTZ facilities.
• PET e.V. (Berlin PET/CT Symposium)minorStrategic or Co-development PartnerDTZ co-organizes the annual Berliner PET/CT Symposium with PET e.V. (a professional nuclear medicine association). The symposium, now in its 23rd edition (2026), serves as a key professional education and networking event for nuclear medicine and radiology professionals.
• Dr. Ulrich Herold (Radiologist and Nuclear Medicine Physician, Köpenick)minorStrategic or Co-development PartnerSince April 1, 2017, DTZ Berlin has cooperated in an überörtliche Berufsausübungsgemeinschaft (cross-location professional practice association) with Dr. Ulrich Herold, a radiologist and nuclear medicine physician based in Berlin-Köpenick.
• alesco.concepts (Communication Agency)minorOthersalesco.concepts (Berlin) handles DTZ's press relations, communication, and visual branding. They manage the Berliner PET/CT Symposium organization and serve as the press contact for DTZ (Sabine Thürk, Thomas Wendland).

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Market position

Competitive moat6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/dtz-am-frankfurter-tor-diagnostisch-therapeutisches-zentrum

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DTZ Am Frankfurter Tor Diagnostisch Therapeutisches Zentrum